---
title: "Pharmaceutical stocks rise against the trend, Hehua Co., Ltd. hits the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223745965.md"
description: "36Kr learned that as of the time of publication, pharmaceutical stocks rose against the trend, with Hehua Co., Ltd. hitting the daily limit, and Sito Bio, SHANGHAI YIZHONG, Hanyu Pharmaceutical, DEZHAN HEALTHCARE, HNPOLY, and others leading in gains"
datetime: "2025-01-02T01:56:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223745965.md)
  - [en](https://longbridge.com/en/news/223745965.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223745965.md)
generator: "portal-rs"
---

# Pharmaceutical stocks rise against the trend, Hehua Co., Ltd. hits the daily limit

36Kr learned that, as of the time of publication, pharmaceutical stocks are rising against the trend, with Hehua Co., Ltd. hitting the daily limit, and Sito Bio, SHANGHAI YIZHONG, Hanyu Pharmaceutical, DEZHAN HEALTHCARE, HNPOLY, and others leading in gains

### Related Stocks

- [000813.CN](https://longbridge.com/en/quote/000813.CN.md)
- [300583.CN](https://longbridge.com/en/quote/300583.CN.md)
- [688091.CN](https://longbridge.com/en/quote/688091.CN.md)
- [000953.CN](https://longbridge.com/en/quote/000953.CN.md)
- [300199.CN](https://longbridge.com/en/quote/300199.CN.md)

## Related News & Research

- [Frogbet Launches Crypto Casino With 70 In- House Original Games, Instant Withdrawals and a $10,000 Weekly Race](https://longbridge.com/en/news/297616927.md)
- [CSPC’s SYS6010 Wins Third Breakthrough Therapy Tag in High-Need Cancer Indications](https://longbridge.com/en/news/297638498.md)
- [H.U. Group unit Fujirebio wins Health Canada licenses for Lumipulse neurology blood tests](https://longbridge.com/en/news/297597814.md)
- [NFL keen for Australia game to become annual fixture in 'strategic' market](https://longbridge.com/en/news/297601499.md)
- [Cleveland Cavaliers partner with DAZN for exclusive local game streaming from 2026-27 season](https://longbridge.com/en/news/297696623.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**